Menin and bone metabolism

Journal of Bone and Mineral Metabolism

Volumn 30, Issue 4, 2012, Pages 381-387

  Kaji, Hiroshi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Menin; Multiple endocrine neoplasia; Osteoblast; Parathyroid

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; LYMPHOID ENHANCER FACTOR 1; METHIONINE; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

BONE DENSITY; BONE METABOLISM; BONE MINERALIZATION; CALCIUM METABOLISM; CELL DIFFERENTIATION; ENDOCRINE TUMOR; GENE; GENE DELETION; HUMAN; MEN1 GENE; MESENCHYMAL STEM CELL; MESENCHYME CELL; MINERAL METABOLISM; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARATHYROID TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SPORADIC ENDOCRINE TUMOR; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BETA CATENIN; BONE AND BONES; CELL DIFFERENTIATION; HUMANS; MINERALS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; ORGAN SPECIFICITY; OSTEOBLASTS; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION;

EID: 84863868180     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-012-0355-3     Document Type: Review

References (61)

1. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS et al (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407
2. Thakker RV (2010) Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab 24:355-370
3. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, Chandrasekharappa SC (1998) Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95:1630-1634 (Pubitemid 28103444)
4. Kaji H, Canaff L, Goltzman D, Hendy GN (1999) Cell cycle regulation of menin expression. Cancer Res 59:5097-5101 (Pubitemid 29503966)
5. Hendy GN, Kaji H, Sowa H, Lebrun JJ, Canaff L (2005) Menin and TGF-β superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast. Horm Metab Res 37:375-379 (Pubitemid 41008772)
6. Hendy GN, Kaji H, Canaff L (2009) Cellular functions of menin. Adv Exp Med Biol 668:37-50
7. Kaji H, Canaff L, Hendy GN (2009) Role of menin in bone development. Adv Exp Med Biol 668:59-67
8. Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN (2001) Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling. Proc Natl Acad Sci USA 98:3837-3842 (Pubitemid 32249858)
9. Hata A (2001) TGF-β signaling and cancer. Exp Cell Res 264:111-116
10. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558-15563 (Pubitemid 44625631)
11. Agarwal SK, Mateo CM, Marx SJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94:1826-1834
12. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL (2005) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102:749-754 (Pubitemid 40282737)
13. Scappaticci S, Maraschio P, del Ciotto N, Fossati GS, Zonta A, Fraccaro M (1991) Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type 1. Cancer Genet Cytogenet 52:85-92
14. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD, Hua X (2003) Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63:4204-4210 (Pubitemid 36917947)
15. Busygina V, Kottemann MC, Scott KL, Plon SE, Bale AE (2006) Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. Cancer Res 66:8397-8403 (Pubitemid 44449150)
16. Busygina V, Suphapeetiporn K, Marek LR, Stowers RS, Xu T, Bale AE (2004) Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1. Hum Mol Genet 13:2399-2408 (Pubitemid 39377844)
17. Hessman O, Skogseid B, Westin G, Akerström G (2001) Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. J Clin Endocrinol Metab 86:1355-1361 (Pubitemid 32323028)
18. Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ, Spiegel AM, Libutti SK (2009) Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type 1 syndrome via Pdx1-directed inactivation of Men1. Cancer Res 69:1858-1866
19. Hsi E, Zukerberg LR, Yang WI, Arnold A (1996) Cyclin D1 (PRAD1) expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 81:1736-1739 (Pubitemid 26152455)
20. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A (2001) Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:1093-1102 (Pubitemid 32422906)
21. Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, Goretzki P, Larsson C (1996) Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 81:3194-3196 (Pubitemid 26296187)
22. Juhlin CC, Nilsson IL, Johansson K, Haglund F, Villablanca A, Höög A, Larsson C (2010) Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr Pathol 21:166-177
23. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR et al (1997) Somatic mutation of the MEN1 gene in parathyroid tumors. Nat Genet 16:375-378 (Pubitemid 27323304)
24. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS (2001) Characterization of the mouse Men1 gene and its expression during development. Proc Natl Acad Sci USA 17:2485-2493
25. Libutti SK, Crabtree JS, Lorang D, Burns AL, Mazzanti C, Hewitt SM, O'Connor S, Ward JM, Emmert-Buck MR, Remaley A, Miller M, Turner E, Alexander HR, Arnold A, Marx SJ, Collins FS, Spiegel AM (2003) Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Res 63:8022-8028 (Pubitemid 37466741)
26. Sowa H, Kaji H, Kitazawa R, Kitazawa S, Tsukamoto T, Yano S, Tsukada T, Canaff L, Hendy GN, Sugimoto T, Chihara K (2004) Menin inactivation leads to loss of transforming growth factor b inhibition of parathyroid cell proliferation and parathyroid hormone secretion. Cancer Res 64:2222-2228 (Pubitemid 38339476)
27. Naito J, Kaji H, Sowa H, Kitazawa R, Kitazawa S, Tsukada T, Hendy GN, Sugimoto T, Chihara K (2006) Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene. Endocrine 29:485-490 (Pubitemid 44358839)
28. Sayo Y, Murao K, Imachi H, Cao WM, Sato M, Dobashi H, Wong NC, Ishida T (2002) The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology 143:2437-2440 (Pubitemid 34521590)
29. Namihira H, Sato M, Murao K, Cao WM, Matsubara S, Imachi H, Niimi M, Dobashi H, Wong NC, Ishida T (2002) The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity. J Mol Endocrinol 29:297-304 (Pubitemid 36024546)
30. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, Fontaine M, Yen MH, Kim SK (2007) Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318:806-809 (Pubitemid 351411773)
31. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D et al (1998) Characterization of the mouse Men1 gene and its expression during development. Oncogene 17:2485-2493 (Pubitemid 28544718)
32. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, Xue A, Montag AG, Luu HH, Haydon RC, He TC (2008) Regulation of osteogenic differentiation during skeletal development. Front Biosci 13:2001-2021 (Pubitemid 351589231)
33. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K (2002) Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res 17:1190-1199 (Pubitemid 34680495)
34. Inoue Y, Canaff L, Hendy GN, Hisa I, Sugimoto T, Chihara K, Kaji H (2009) Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells. J Cell Biochem 108:285-294
35. Sowa H, Kaji H, Canaff L, Hendy GN, Tsukamoto T, Yamaguchi T, Miyazono K, Sugimoto T, Chihara K (2003) Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J Biol Chem 278:21058-21069 (Pubitemid 36806417)
36. Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chiahra K (2004) Menin is required for bone morphogenetic protein2- and transforming growth factor-β-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 279:40267-40275 (Pubitemid 39287610)
37. Aziz A, Miyake T, Engleka KA, Epstein JA, McDermott JC (2009) Menin expression modulates mesenchymal cell commitment to the myogenic and osteogenic lineages. Dev Biol 332:116-130
38. Dreijerink KMA, Varier RA, van Beekum O, Jeninga EH, Hoppner JWM, Lips CJM, Kummer JA, Kalkhoven E, Timmers HTM (2009) The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor γ-dependent adipocyte differentiation. Mol Cell Biol 29:5060-5069
39. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96:143-152 (Pubitemid 29044161)
40. Kim H, Lee JE, Cho EJ, Liu JO, Youn HD (2003) Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 63:6135-6139 (Pubitemid 37255151)
41. Agarwal SK, Novotny EA, Crabtree JS, Witzman JB, Yaniv M, Burns AL, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ (2003) Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci USA 100:10770-10775 (Pubitemid 37140103)
42. Naito J, Kaji H, Sowa H, Hendy GN, Sugimoto T, Chihara K (2005) Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD. J Biol Chem 280:4785-4791 (Pubitemid 40288650)
43. Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, Hendy GN, Sugimoto T, Chihara K (2006) Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147:2583-2590
44. Hisa I, Inoue Y, Hendy GN, Canaff L, Kitazawa R, Kitazawa S, Komori T, Sugimoto T, Seino S, Kaji H (2011) Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. J Biol Chem 286:9787-9796
45. Rowadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853 (Pubitemid 37322562)
46. Chen Y, Whetstone HC, Youn A, Nudesan P, Chow EC, Lin AC, Alman BA (2007) β-Catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 282:526-533 (Pubitemid 47076655)
47. Inoue Y, Hendy GN, Canaff L, Seino S, Kaji H (2011) Menin interacts with β-catenin in osteoblast differentiation. Horm Metab Res 43:183-187
48. Chen G, Jingbo AJ, Wang M, Farley S, Lee LC, Sawicki MP (2008) Menin promotes the Wnt signaling pathway in pancreatic endocrine cells. Mol Cancer Res 6:1894-1907
49. Cao Y, Liu R, Jiang X, Lu J, Jiang J, Zhang C, Li X, Ning G (2009) Nuclear-cytoplasmic shuttling of menin regulates translocation of β-catenin. Mol Cell Biol 29:5477-5487
50. Bertolino P, Tong WM, Herrerra PL, Casse H, Zhang CX, Wang ZQ (2003) Pancreatic β-cell specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res 63:4836-4841 (Pubitemid 37022614)
51. Lin SY, Elledge SJ (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113:881-889
52. Maillard I, Chen YX, Friedman A, Yang Y, Tubbs AT, Shestova O, Pear WS, Hua X (2009) Menin regulates the function of hematopoietic stem cells and lymphoid progenitors. Blood 113:1661-1669
53. van Kesteren RE, Syed NI, Munno DW, Bouwman J, Feng ZP, Geraerts WPM, Smit AB (2001) Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene. J Neurosci 21:RC161
54. Cheng P, Yang SS, Hu XG, Zhou XY, Zhang YJ, Zhang YJ, Jin YJ, Zhou YQ (2011) Menin prevents liver steatosis through coactivation of peroxisome proliferator-activated receptor alpha. FEBS Lett 585:3403-3408
55. Engleka KA, Wu M, Zhang M, Antonucci NB, Epstein JA (2007) Menin is required in cranial neural crest for palatogenesis and perinatal viability. Dev Biol 311:524-537 (Pubitemid 350046543)
56. Kanazawa I, Nayak G, Canaff L, Murshed M, Hendy GN (2011) Reduced accumulation of bone in mice lacking the Men1 gene in osteoblasts. J Bone Miner Res 26:s309
57. Loffler KA, Biondi CA, Gartside MG, Serewko-Auret MM, Duncan R, Tonks ID, Mould AW, Waring P, Muller HK, Kay GF, Hayward NK (2007) Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice. Oncogene 26:4009-4017 (Pubitemid 46884290)
58. Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT (2006) Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 66:4929-4935
59. Chen YX, Yan J, Keeshan K, Tubbs AT, Wang H, Silva A, Brown EJ, Hess JL, Pear WS, Hua X (2006) The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc Natl Acad Sci USA 103:1018-1023 (Pubitemid 43212214)
60. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA, Kay GF, Hayward NK, Hess JL, Meyerson M (2004) Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13:587-597 (Pubitemid 38299385)
61. La P, Schnepp RW, Petersen CD, C Silva A, Hua X (2004) Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2. Endocrinology 145:3443-3450 (Pubitemid 38830017)